. Author manuscript; available in PMC: 2011 Apr 15.

Published in final edited form as: J Neuroimmunol. 2010 Feb 1;221(1-2):112–114. doi: 10.1016/j.jneuroim.2010.01.005

Table 1.

Description of the analyzed samples and clinical features of MS patients

	Controls	MS patients
Samples	N	N	Age at Onset^b	Female:Male Ratio	EDSS %			Disease Course %
Samples	N	N	Age at Onset^b	Female:Male Ratio	<3	3 to <6	≥6	RR	SP	PP	PR
Italy	628	827	32.5±10.5	2:1	53	28	19	76	12	10	2
UK	10029^a	2210	29.8±9.4	2.7:1	30	26	44	59	31	10	0

Notes: MS: Multiple Sclerosis; EDSS: Expanded Disability Status Scale (Kurtzke, 1983); RR: Relapsing Remitting; SP: Secondary Progressive; PP: Primary Progressive; PR: Progressive Relapsing.

Controls included in the paper by Nejentsev et al. (Nejentsev et al., 2009), with the exception of 467 new samples.

Mean ± Standard Deviation.